Lineage Cell Therapeutics
LCTX
LCTX
57 hedge funds and large institutions have $70M invested in Lineage Cell Therapeutics in 2014 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 19 increasing their positions, 19 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
8% less funds holding
Funds holding: 62 → 57 (-5)
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
90% less call options, than puts
Call options by funds: $59K | Put options by funds: $575K
Holders
57
Holding in Top 10
1
Calls
$59K
Puts
$575K
Top Buyers
| 1 | +$1.16M | |
| 2 | +$397K | |
| 3 | +$363K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$313K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$304K |
Top Sellers
| 1 | -$385K | |
| 2 | -$379K | |
| 3 | -$224K | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$149K |
| 5 |
Jane Street
New York
|
-$69K |